| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.3 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.3 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |